Bayer's Latest Roundup Weedkiller Trial Postponed Amid Settlement Talks
January 24 2020 - 3:21PM
Dow Jones News
By Laura Kusisto and Ruth Bender
ST. LOUIS -- The latest trial over allegations that Bayer AG's
popular Roundup weedkiller causes cancer was postponed indefinitely
at the last minute on Friday to allow room for escalating
settlement talks to continue.
Bayer was hours away from facing another jury on the issue,
after the German chemical and drug conglomerate over the last year
and a half lost the first three Roundup trials for a total of
$190.5 million in awards. A fourth adverse verdict could have
handed plaintiffs, who number more than 42,000, additional
ammunition in settlement talks that have dragged on for months.
Analysts estimate any settlement would be in the $8 billion to
$12 billion range, in talks led by court-appointed mediator Ken
Feinberg, who said he was "cautiously optimistic" a deal could be
struck in the coming weeks.
A Friday order from Judge Elizabeth Hogan said simply
"cause(sic) continued" in handwritten print. A Bayer spokesman
confirmed the case is delayed indefinitely, "to provide room for
the parties to continue the mediation process in good faith ... and
avoid the distractions that can arise from trials."
He added that, "there is no comprehensive agreement at this
time. There also is no certainty or timetable for a comprehensive
resolution."
(END) Dow Jones Newswires
January 24, 2020 15:06 ET (20:06 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Bayer (TG:BAYN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Bayer (TG:BAYN)
Historical Stock Chart
From Apr 2023 to Apr 2024